SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 11/30/22 – ‘EX-101.SCH’

On:  Friday, 5/19/23, at 1:48pm ET   ·   For:  11/30/22   ·   Accession #:  1393905-23-233   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q’ on 4/19/23 for 8/31/22   ·   Next:  ‘10-Q’ on 6/29/23 for 2/28/23   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   26 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Cell Medx Corp. - Form 10-Q SEC Filing              HTML    555K 
 2: EX-10.67    Loan Agreement Dated April 11, 2023, Among Cell     HTML     21K 
                Medx Corp. and Amir Vahabzadeh                                   
 3: EX-10.68    Loan Agreement Dated April 25, 2023, Among Cell     HTML     21K 
                Medx Corp. and David Jeffs                                       
 4: EX-31.1     Certification of Principal Executive Officer        HTML     19K 
 5: EX-31.2     Certification of Principal Financial Officer        HTML     19K 
 6: EX-32.1     Certification of Principal Executive Officer        HTML     16K 
 7: EX-32.2     Certification of Principal Financial Officer        HTML     16K 
13: R1          Document and Entity Information                     HTML     65K 
14: R2          Condensed Consolidated Balance Sheets               HTML     85K 
15: R3          Condensed Consolidated Balance Sheets -             HTML     23K 
                Parenthetical                                                    
16: R4          Condensed Consolidated Statements of Operations     HTML     84K 
17: R5          Condensed Consolidated Statement of Stockholders'   HTML     80K 
                Deficit                                                          
18: R6          Condensed Consolidated Statements of Cash Flows     HTML     70K 
19: R7          Organization and Nature of Operations               HTML     22K 
20: R8          Related Party Transactions Disclosure               HTML     36K 
21: R9          Notes and Advances Payable Disclosure               HTML     39K 
22: R10         Other Current Assets Disclosure                     HTML     18K 
23: R11         Equipment Disclosure                                HTML     23K 
24: R12         Revenue Disclosure                                  HTML     28K 
25: R13         Notes and Advances Payable Disclosure, Current      HTML     18K 
26: R14         Share Capital Disclosure                            HTML     40K 
27: R15         Subsequent Events Disclosure                        HTML     20K 
28: R16         Related Party Transactions Disclosure: Schedule of  HTML     24K 
                Amounts Due to Related Parties (Tables)                          
29: R17         Related Party Transactions Disclosure: Schedule of  HTML     26K 
                Transactions with Related Parties (Tables)                       
30: R18         Notes and Advances Payable Disclosure: Schedule of  HTML     29K 
                Loans and Advances Outstanding to Related Parties                
                (Tables)                                                         
31: R19         Equipment Disclosure: Change in book value of the   HTML     22K 
                equipment (Tables)                                               
32: R20         Revenue Disclosure: Schedule of Revenue and         HTML     28K 
                Associated Costs (Tables)                                        
33: R21         Share Capital Disclosure: Schedule of Stock Option  HTML     25K 
                Activity (Tables)                                                
34: R22         Share Capital Disclosure: Schedule of Warrant       HTML     25K 
                Activity (Tables)                                                
35: R23         Share Capital Disclosure: Schedule of Warrant       HTML     21K 
                Details (Tables)                                                 
36: R24         Organization and Nature of Operations (Details)     HTML     20K 
37: R25         Related Party Transactions Disclosure: Schedule of  HTML     29K 
                Amounts Due to Related Parties (Details)                         
38: R26         Related Party Transactions Disclosure: Schedule of  HTML     30K 
                Transactions with Related Parties (Details)                      
39: R27         Notes and Advances Payable Disclosure: Schedule of  HTML     29K 
                Loans and Advances Outstanding to Related Parties                
                (Details)                                                        
40: R28         Notes and Advances Payable Disclosure (Details)     HTML     68K 
41: R29         Other Current Assets Disclosure (Details)           HTML     20K 
42: R30         Equipment Disclosure: Change in book value of the   HTML     24K 
                equipment (Details)                                              
43: R31         Revenue Disclosure: Schedule of Revenue and         HTML     40K 
                Associated Costs (Details)                                       
44: R32         Notes and Advances Payable Disclosure, Current      HTML     25K 
                (Details)                                                        
45: R33         Share Capital Disclosure: Schedule of Stock Option  HTML     26K 
                Activity (Details)                                               
46: R34         Share Capital Disclosure: Schedule of Warrant       HTML     23K 
                Activity (Details)                                               
47: R35         Share Capital Disclosure: Schedule of Warrant       HTML     20K 
                Details (Details)                                                
48: R36         Subsequent Events Disclosure (Details)              HTML     30K 
51: XML         IDEA XML File -- Filing Summary                      XML     89K 
49: XML         XBRL Instance -- cmxc-20221130_htm                   XML    573K 
50: EXCEL       IDEA Workbook of Financial Reports                  XLSX     60K 
 8: EX-101.CAL  XBRL Calculations -- cmxc-20221130_cal               XML     51K 
 9: EX-101.DEF  XBRL Definitions -- cmxc-20221130_def                XML    213K 
10: EX-101.LAB  XBRL Labels -- cmxc-20221130_lab                     XML    383K 
11: EX-101.PRE  XBRL Presentations -- cmxc-20221130_pre              XML    334K 
12: EX-101.SCH  XBRL Schema -- cmxc-20221130                         XSD     95K 
52: JSON        XBRL Instance as JSON Data -- MetaLinks              188±   278K 
53: ZIP         XBRL Zipped Folder -- 0001393905-23-000233-xbrl      Zip    110K

‘EX-101.SCH’   —   XBRL Schema — cmxc-20221130

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2023 [PPXC4Y912124VDCJENC7]. www.edgarsuite.com -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:fil="http://cellmedx.com/20221130" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" targetNamespace="http://cellmedx.com/20221130" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" elementFormDefault="qualified" attributeFormDefault="unqualified">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cmxc-20221130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cmxc-20221130_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cmxc-20221130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cmxc-20221130_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosure" id="idr_DisclosureShareCapitalDisclosure">
<link:definition> 000140 - Disclosure - Share Capital Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRelatedPartyTransactionsDisclosure" id="idr_DisclosureRelatedPartyTransactionsDisclosure">
<link:definition> 000080 - Disclosure - Related Party Transactions Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureOtherCurrentAssetsDisclosure" id="idr_DisclosureOtherCurrentAssetsDisclosure">
<link:definition> 000100 - Disclosure - Other Current Assets Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureOtherCurrentAssetsDisclosureDetails" id="idr_DisclosureOtherCurrentAssetsDisclosureDetails">
<link:definition> 000290 - Disclosure - Other Current Assets Disclosure (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_StatementCondensedConsolidatedStatementsOfCashFlows" id="idr_StatementCondensedConsolidatedStatementsOfCashFlows">
<link:definition> 000060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityDetails" id="idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityDetails">
<link:definition> 000330 - Disclosure - Share Capital Disclosure: Schedule of Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesTables" id="idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesTables">
<link:definition> 000170 - Disclosure - Related Party Transactions Disclosure: Schedule of Transactions with Related Parties (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesDetails" id="idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesDetails">
<link:definition> 000250 - Disclosure - Related Party Transactions Disclosure: Schedule of Amounts Due to Related Parties (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureOrganizationAndNatureOfOperations" id="idr_DisclosureOrganizationAndNatureOfOperations">
<link:definition> 000070 - Disclosure - Organization and Nature of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosureCurrentDetails" id="idr_DisclosureNotesAndAdvancesPayableDisclosureCurrentDetails">
<link:definition> 000320 - Disclosure - Notes and Advances Payable Disclosure, Current (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfLoansAndAdvancesOutstandingToRelatedPartiesDetails" id="idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfLoansAndAdvancesOutstandingToRelatedPartiesDetails">
<link:definition> 000270 - Disclosure - Notes and Advances Payable Disclosure: Schedule of Loans and Advances Outstanding to Related Parties (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_StatementCondensedConsolidatedStatementsOfOperations" id="idr_StatementCondensedConsolidatedStatementsOfOperations">
<link:definition> 000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesDetails" id="idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfTransactionsWithRelatedPartiesDetails">
<link:definition> 000260 - Disclosure - Related Party Transactions Disclosure: Schedule of Transactions with Related Parties (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosure" id="idr_DisclosureNotesAndAdvancesPayableDisclosure">
<link:definition> 000090 - Disclosure - Notes and Advances Payable Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureSubsequentEventsDisclosureDetails" id="idr_DisclosureSubsequentEventsDisclosureDetails">
<link:definition> 000360 - Disclosure - Subsequent Events Disclosure (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfLoansAndAdvancesOutstandingToRelatedPartiesTables" id="idr_DisclosureNotesAndAdvancesPayableDisclosureScheduleOfLoansAndAdvancesOutstandingToRelatedPartiesTables">
<link:definition> 000180 - Disclosure - Notes and Advances Payable Disclosure: Schedule of Loans and Advances Outstanding to Related Parties (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureEquipmentDisclosure" id="idr_DisclosureEquipmentDisclosure">
<link:definition> 000110 - Disclosure - Equipment Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRevenueDisclosure" id="idr_DisclosureRevenueDisclosure">
<link:definition> 000120 - Disclosure - Revenue Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityDetails" id="idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityDetails">
<link:definition> 000340 - Disclosure - Share Capital Disclosure: Schedule of Warrant Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityTables" id="idr_DisclosureShareCapitalDisclosureScheduleOfStockOptionActivityTables">
<link:definition> 000210 - Disclosure - Share Capital Disclosure: Schedule of Stock Option Activity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesTables" id="idr_DisclosureRelatedPartyTransactionsDisclosureScheduleOfAmountsDueToRelatedPartiesTables">
<link:definition> 000160 - Disclosure - Related Party Transactions Disclosure: Schedule of Amounts Due to Related Parties (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_StatementCondensedConsolidatedStatementOfStockholdersDeficit" id="idr_StatementCondensedConsolidatedStatementOfStockholdersDeficit">
<link:definition> 000050 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityTables" id="idr_DisclosureShareCapitalDisclosureScheduleOfWarrantActivityTables">
<link:definition> 000220 - Disclosure - Share Capital Disclosure: Schedule of Warrant Activity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureEquipmentDisclosureChangeInBookValueOfTheEquipmentDetails" id="idr_DisclosureEquipmentDisclosureChangeInBookValueOfTheEquipmentDetails">
<link:definition> 000300 - Disclosure - Equipment Disclosure: Change in book value of the equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsTables" id="idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsTables">
<link:definition> 000230 - Disclosure - Share Capital Disclosure: Schedule of Warrant Details (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
<link:definition> 000010 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureEquipmentDisclosureChangeInBookValueOfTheEquipmentTables" id="idr_DisclosureEquipmentDisclosureChangeInBookValueOfTheEquipmentTables">
<link:definition> 000190 - Disclosure - Equipment Disclosure: Change in book value of the equipment (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosureCurrent" id="idr_DisclosureNotesAndAdvancesPayableDisclosureCurrent">
<link:definition> 000130 - Disclosure - Notes and Advances Payable Disclosure, Current </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_StatementCondensedConsolidatedBalanceSheets" id="idr_StatementCondensedConsolidatedBalanceSheets">
<link:definition> 000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRevenueDisclosureScheduleOfRevenueAndAssociatedCostsTables" id="idr_DisclosureRevenueDisclosureScheduleOfRevenueAndAssociatedCostsTables">
<link:definition> 000200 - Disclosure - Revenue Disclosure: Schedule of Revenue and Associated Costs (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureSubsequentEventsDisclosure" id="idr_DisclosureSubsequentEventsDisclosure">
<link:definition> 000150 - Disclosure - Subsequent Events Disclosure </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureOrganizationAndNatureOfOperationsDetails" id="idr_DisclosureOrganizationAndNatureOfOperationsDetails">
<link:definition> 000240 - Disclosure - Organization and Nature of Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureNotesAndAdvancesPayableDisclosureDetails" id="idr_DisclosureNotesAndAdvancesPayableDisclosureDetails">
<link:definition> 000280 - Disclosure - Notes and Advances Payable Disclosure (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_StatementCondensedConsolidatedBalanceSheetsParenthetical" id="idr_StatementCondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 000030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - Parenthetical </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsDetails" id="idr_DisclosureShareCapitalDisclosureScheduleOfWarrantDetailsDetails">
<link:definition> 000350 - Disclosure - Share Capital Disclosure: Schedule of Warrant Details (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cellmedx.com/20221130/role/idr_DisclosureRevenueDisclosureScheduleOfRevenueAndAssociatedCostsDetails" id="idr_DisclosureRevenueDisclosureScheduleOfRevenueAndAssociatedCostsDetails">
<link:definition> 000310 - Disclosure - Revenue Disclosure: Schedule of Revenue and Associated Costs (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
</appinfo>
</annotation>
<import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" id="fil_Reserves" name="Reserves"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToTheCeoMember" name="DueToTheCeoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToCfoMember" name="DueToCfoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToVpOfTechnologyAndOperationsMember" name="DueToVpOfTechnologyAndOperationsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ManagementFeesIncurredToACeoMember" name="ManagementFeesIncurredToACeoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ManagementFeesIncurredToTheCfoMember" name="ManagementFeesIncurredToTheCfoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" name="ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_PrepaidExpensesMember" name="PrepaidExpensesMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" name="ReceivablesAssociatedWithGstCellMedxCanadaMember"/>
<element nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ScheduleOfWarrantActivityTextBlock" name="ScheduleOfWarrantActivityTextBlock"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_Reserves1Member" name="Reserves1Member"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_CostOfEbalanceDevicesMember" name="CostOfEbalanceDevicesMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RoyaltyPayableForEbalanceDevicesMember" name="RoyaltyPayableForEbalanceDevicesMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_WarrantsGrantedJan2920201Member" name="WarrantsGrantedJan2920201Member"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_WarrantsGrantedJan2920202Member" name="WarrantsGrantedJan2920202Member"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" id="fil_NonCashIrFees" name="NonCashIrFees"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" name="DueToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" name="ConsultingFeesIncurredToACompanyControlledByOurCooMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToACompanyControlledByOurCooMember" name="DueToACompanyControlledByOurCooMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" name="DueToACompanyOfWhichTheCooIsADirectorOfMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_MonthlySubscMember" name="MonthlySubscMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_AdvancesDaCostaManagementMember" name="AdvancesDaCostaManagementMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_BrekTechMember" name="BrekTechMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_N3RelatedPartyLoansPayableJeffsMember" name="N3RelatedPartyLoansPayableJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RelatedPartyLoansPayableMrsJeffsMember" name="RelatedPartyLoansPayableMrsJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" name="RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" name="RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_SalesOfEbalanceDevicesMember" name="SalesOfEbalanceDevicesMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" name="LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_DueToADirectorAndTheFormerCeoMember" name="DueToADirectorAndTheFormerCeoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" name="ManagementFeesIncurredToADirectorAndTheFormerCeoMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RelatedPartyLoansPayableMember" name="RelatedPartyLoansPayableMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RelatedPartyAdvancesMember" name="RelatedPartyAdvancesMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_CellMedxCanadaLoansToMrJeffsMember" name="CellMedxCanadaLoansToMrJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoansToDavidJeffsMember" name="LoansToDavidJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoansToACompanyDavidJeffsIsADirectorOfMember" name="LoansToACompanyDavidJeffsIsADirectorOfMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_AdvancesFromDavidJeffsMember" name="AdvancesFromDavidJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_NotesAndAdvancesNotRelatedMember" name="NotesAndAdvancesNotRelatedMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoansOtherMember" name="LoansOtherMember"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" id="fil_ConsolidationOfLoans" name="ConsolidationOfLoans"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" id="fil_DueToRelatedPartyCurrent" name="DueToRelatedPartyCurrent"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" id="fil_NotesAndAdvancesDueToRelatedParties" name="NotesAndAdvancesDueToRelatedParties"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" id="fil_NotesPayableRelatedPartiesOther" name="NotesPayableRelatedPartiesOther"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" id="fil_RelatedPartyPayablesLoans" name="RelatedPartyPayablesLoans"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoansOther2Member" name="LoansOther2Member"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RelatedPartyLoanUnsecuredRichardJeffsMember" name="RelatedPartyLoanUnsecuredRichardJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_RelatedPartyLoanSecuredRichardJeffsMember" name="RelatedPartyLoanSecuredRichardJeffsMember"/>
<element abstract="true" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_LoansToDavidJeffs2Member" name="LoansToDavidJeffs2Member"/>
<element nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" id="fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" name="ScheduleOfTransactionsWithRelatedPartiesTextBlock"/>
<element nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" id="fil_ForeignExchangeEquipmentGL" name="ForeignExchangeEquipmentGL"/>
<element nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" id="fil_NumberOfWarrantsExercisable" name="NumberOfWarrantsExercisable"/>
</schema>

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc

21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
10/18/22  Cell MedX Corp.                   8-K:1,7,8,910/11/22   17:284K                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 5/26/21  Cell MedX Corp.                   8-K:1,3,7,9 5/24/21    4:95K                                    Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA
↑Top
Filing Submission 0001393905-23-000233   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 10, 1:31:35.3pm ET